These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7881465)

  • 21. Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cells.
    Donat SM; Powell CT; Israeli RS; Fair WR; Heston WD
    J Natl Cancer Inst; 1995 Jan; 87(1):41-6. PubMed ID: 7666462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequencing hormonal ablation and radiotherapy in prostate cancer: a molecular and therapeutic prespective (Review).
    Hill B; Kyprianou N
    Oncol Rep; 2002; 9(6):1151-6. PubMed ID: 12375010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells.
    Woynarowska BA; Roberts K; Woynarowski JM; MacDonald JR; Herman TS
    Radiat Res; 2000 Oct; 154(4):429-38. PubMed ID: 11023607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.
    Vukanovic J; Isaacs JT
    Cancer Res; 1995 Aug; 55(16):3517-20. PubMed ID: 7543015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient tyrosine phosphorylation of p34cdc2 is an early event in radiation-induced apoptosis of prostate cancer cells.
    Kyprianou N; Bains A; Rhee JG
    Prostate; 1997 Sep; 32(4):266-71. PubMed ID: 9288185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.
    Gupta S; Ahmad N; Nieminen AL; Mukhtar H
    Toxicol Appl Pharmacol; 2000 Apr; 164(1):82-90. PubMed ID: 10739747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer.
    Xie X; Zhao X; Liu Y; Zhang J; Matusik RJ; Slawin KM; Spencer DM
    Cancer Res; 2001 Sep; 61(18):6795-804. PubMed ID: 11559553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
    Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype].
    Bonkhoff H; Fixemer T
    Urologe A; 2004 Jul; 43(7):836-42. PubMed ID: 15048555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suramin's development: what did we learn?
    Kaur M; Reed E; Sartor O; Dahut W; Figg WD
    Invest New Drugs; 2002 May; 20(2):209-19. PubMed ID: 12099581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation.
    Joon DL; Hasegawa M; Sikes C; Khoo VS; Terry NH; Zagars GK; Meistrich ML; Pollack A
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1071-7. PubMed ID: 9276374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells.
    Gao J; Isaacs JT
    Cancer Res; 1998 Aug; 58(15):3299-306. PubMed ID: 9699659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen deprivation and four courses of fixed-schedule suramin treatment in patients with newly diagnosed metastatic prostate cancer: A Southwest Oncology Group Study.
    Hussain M; Fisher EI; Petrylak DP; O'Connor J; Wood DP; Small EJ; Eisenberger MA; Crawford ED
    J Clin Oncol; 2000 Mar; 18(5):1043-9. PubMed ID: 10694555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low apoptotic activity in primary prostate carcinomas without response to hormonal therapy.
    Palmberg C; Rantala I; Tammela TL; Helin H; Koivisto PA
    Oncol Rep; 2000; 7(5):1141-4. PubMed ID: 10948353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
    Miyake H; Chi KN; Gleave ME
    Clin Cancer Res; 2000 May; 6(5):1655-63. PubMed ID: 10815883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process.
    Craft N; Chhor C; Tran C; Belldegrun A; DeKernion J; Witte ON; Said J; Reiter RE; Sawyers CL
    Cancer Res; 1999 Oct; 59(19):5030-6. PubMed ID: 10519419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of hormone deprivation and 2-methoxyestradiol combination therapy on hormone-dependent prostate cancer in vivo.
    Sato F; Fukuhara H; Basilion JP
    Neoplasia; 2005 Sep; 7(9):838-46. PubMed ID: 16229806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C16 ceramide accumulates following androgen ablation in LNCaP prostate cancer cells.
    Eto M; Bennouna J; Hunter OC; Hershberger PA; Kanto T; Johnson CS; Lotze MT; Amoscato AA
    Prostate; 2003 Sep; 57(1):66-79. PubMed ID: 12886525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway.
    Kim IY; Seong DH; Kim BC; Lee DK; Remaley AT; Leach F; Morton RA; Kim SJ
    Cancer Res; 2002 Jul; 62(13):3649-53. PubMed ID: 12097269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.